GO
Loading...

Merck's new weapon in fight against cancer

Wednesday, 4 Jun 2014 | 8:03 AM ET

Ken Frazier, Merck chairman & CEO, discusses the latest immune drug for treating melanoma and lung cancer. Also Frazier weighs in on the high cost of drugs.